Trevi Therapeutics, Inc. TRVI Options forfeited/expired (in dollars per share)
Options forfeited/expired (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s options forfeited/expired (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s options forfeited/expired (in dollars per share)?
- Trevi Therapeutics, Inc. (TRVI) reported options forfeited/expired (in dollars per share) of $0.00 in Q1 2026.
- What does options forfeited/expired (in dollars per share) mean?
- The weighted-average exercise price associated with stock options that were either forfeited or expired during the reporting period. It serves as a measure of the cost basis of equity awards that failed to vest or were not utilized by recipients.